Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India. It was established in 1944.
Financial Results:
Abbott India Ltd reported Revenues for Q2FY25 of ₹1,628.00 Crores up from ₹497.00 Crore year on year, a rise of 11.97%.
Total Expenses for Q2FY25 of ₹1,601.00 Crores up from ₹1,372.00 Crores year on year, a rise of 16.69%.
Consolidated Net Profit of ₹52.00 Crores down 42.86% from ₹91.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹1.43, Revenue 43.03% from ₹2.51 in the same quarter of the previous year.